CORMEDIX INC.

CRMD
Delayed Quote. Delayed  - 05/17 04:00:01 pm
3.82USD +5.82%

Turn to zoom
Prev.3.8200
Open3.6800
High3.9370
Low3.6800
Volume419 183
Latest news
4d ago
4d ago
4d ago
4d ago
Chart CORMEDIX INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance4,214,215,05
Spread/Res.-14%-14%-29%
Spread/Supp.21%21%13%
Support2,982,983,19
Financials
Sales 2022 0,64 M - -
Net income 2022 -36,5 M - -
Net cash 2022 118 M - -
P/E ratio 2022 -4,15x
Yield 2022 -
Capitalization 141 M 141 M -
EV / Sales 2022 37,0x
EV / Sales 2023 2,56x
Nbr of Employees 30
Free-Float 97,3%
Company
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its lead product candidate, DefenCath, for...

>> Read more
Sector :
Specialty & Advanced Pharmaceuticals
Calendar :
2022-08-16 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 3,61 $
Average target price 22,00 $
Spread / Average Target 509%